Quick Acting Vaccine Combats Cholera | AIChE

Quick Acting Vaccine Combats Cholera


A new cholera vaccine begins protecting rabbits from the fatal disease within 24 hr of injection. With only one U.S. Food and Drug Administration (FDA)-approved vaccine in circulation and an estimated 2.9 million cases of cholera each year, this quick-acting treatment has the potential to save thousands of lives.

Cholera is caused by the bacterium Vibrio cholerae. Infection is characterized by profuse diarrhea and vomiting; without treatment, cholera can spell death through dehydration within a few hours.

A team of researchers from Howard Hughes Medical Institute (HHMI) created the new vaccine using the strain of V. cholerae responsible for the 2010 cholera outbreak in Haiti, which is now the most prominent strain. The other vaccine continues to use strains of V. cholerae that are both extinct and highly pathogenic, says HHMI investigator Matthew Waldor. The extinct cholera...

Would you like to access the complete CEP News Update?

No problem. You just have to complete the following steps.

You have completed 0 of 2 steps.

  1. Log in

    You must be logged in to view this content. Log in now.

  2. AIChE Membership

    You must be an AIChE member to view this article. Join now.

Copyright Permissions 

Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.

Related Topics